New target makes end run against therapy-resistant prostate cancer

Researchers at UC Davis have found that suppressing the nuclear receptor protein ROR-γ with small-molecule compounds can reduce androgen receptor (AR) levels in castration-resistant prostate cancer and stop tumor growth

Read the article.